#skbioscience — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #skbioscience, aggregated by home.social.
-
SK Bioscience strengthens production cooperation with subsidiary IDT Biologika for second-generation Zaire Ebola vaccine development with MSD, expanding its global vaccine production network to address infectious disease outbreaks in Africa including Democratic Republic of Congo.
#YonhapInfomax #SKBioscience #EbolaVaccine #MSD #IDTBiologika #ContractManufacturing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=111388 -
SK Bioscience strengthens production cooperation with subsidiary IDT Biologika for second-generation Zaire Ebola vaccine development with MSD, expanding its global vaccine production network to address infectious disease outbreaks in Africa including Democratic Republic of Congo.
#YonhapInfomax #SKBioscience #EbolaVaccine #MSD #IDTBiologika #ContractManufacturing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=111388 -
SK Bioscience strengthens production cooperation with subsidiary IDT Biologika for second-generation Zaire Ebola vaccine development with MSD, expanding its global vaccine production network to address infectious disease outbreaks in Africa including Democratic Republic of Congo.
#YonhapInfomax #SKBioscience #EbolaVaccine #MSD #IDTBiologika #ContractManufacturing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=111388 -
SK Bioscience strengthens production cooperation with subsidiary IDT Biologika for second-generation Zaire Ebola vaccine development with MSD, expanding its global vaccine production network to address infectious disease outbreaks in Africa including Democratic Republic of Congo.
#YonhapInfomax #SKBioscience #EbolaVaccine #MSD #IDTBiologika #ContractManufacturing #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=111388 -
SK Bioscience reports Q1 operating loss of 15.1 billion won, outperforming market expectations, with sales surge of 594% year-on-year driven by IDT Biologika acquisition and strong vaccine sales
#YonhapInfomax #SKBioscience #Q1Earnings #OperatingLoss #VaccineSales #IDTBiologika #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=61992 -
SK Bioscience reports Q1 operating loss of 15.1 billion won, outperforming market expectations with 594% year-on-year sales growth despite continued losses
#YonhapInfomax #SKBioscience #Q1Earnings #OperatingLoss #SalesGrowth #MarketExpectations #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=61988 -
SK Bioscience reports Q1 operating loss of 15.1 billion won, outperforming market expectations amid challenging biotech landscape
#YonhapInfomax #SKBioscience #Q1Results #OperatingLoss #BiotechIndustry #FinancialPerformance #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=61986